Clinical characteristics of the entire study cohort
| Characteristic . | All patients, n = 176 . |
|---|---|
| Median age, y (range) | 41 (18-74) |
| % of patients younger than 61 y | 92 |
| Male sex, n (%) | 94 (53) |
| AML history, n (%) | |
| De novo | 164 (93) |
| Therapy-related | 12 (7) |
| Median WBC count, × 109/L (range) | 38.8 (1.1-294.9) |
| Missing data, n | 3 |
| Median platelet count, × 109/L (range) | 34 (7-529) |
| Missing data, n | 3 |
| Median hemoglobin, g/dL (range) | 9.2 (2.5-14.5) |
| Missing data, n | 3 |
| Median % blood blasts (range) | 44 (0-97) |
| Missing data, n | 9 |
| Median % bone marrow blasts (range) | 80 (4-99) |
| Missing data, n | 19 |
| Extramedullary involvement, n (%) | |
| Present | 56 (32) |
| Absent | 117 (68) |
| Missing data | 3 |
| Characteristic . | All patients, n = 176 . |
|---|---|
| Median age, y (range) | 41 (18-74) |
| % of patients younger than 61 y | 92 |
| Male sex, n (%) | 94 (53) |
| AML history, n (%) | |
| De novo | 164 (93) |
| Therapy-related | 12 (7) |
| Median WBC count, × 109/L (range) | 38.8 (1.1-294.9) |
| Missing data, n | 3 |
| Median platelet count, × 109/L (range) | 34 (7-529) |
| Missing data, n | 3 |
| Median hemoglobin, g/dL (range) | 9.2 (2.5-14.5) |
| Missing data, n | 3 |
| Median % blood blasts (range) | 44 (0-97) |
| Missing data, n | 9 |
| Median % bone marrow blasts (range) | 80 (4-99) |
| Missing data, n | 19 |
| Extramedullary involvement, n (%) | |
| Present | 56 (32) |
| Absent | 117 (68) |
| Missing data | 3 |